Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,612,270
+$723,325 QoQ
Shares Held
33,631
+39.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#419
of 1,348 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. NVO ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
|
2,801 | $711,369 |
All Filings in NVO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,612,270 | 33,631 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $888,945 | 24,189 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,114,679 | 21,908 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $698,730 | 12,592 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $751,006 | 10,881 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $606,350 | 8,732 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,087,034 | 12,637 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,057,817 | 8,884 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,161,189 | 8,135 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,070,214 | 8,335 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $855,531 | 8,270 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $674,956 | 7,422 | Shares | Sole | 2023-10-25 | |
| No filing history on record for this holder in this stock. | ||||||